Latitude Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Latitude Advisors's AMGN Position: Q4 2024 in Review
Latitude Advisors sold out of Amgen (AMGN) in Q4 2024, closing a stake of 708 shares — an estimated $228K sold.
Latitude Advisors first reported a position in AMGN in Q4 2020 and held it in 15 quarters. The position peaked at $797K in Q1 2022. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Latitude Advisors reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Latitude Advisors sold 708 Amgen shares in Q4 2024, an estimated $228K.
- Latitude Advisors first reported a position in Amgen in Q4 2020 and held it in 15 quarters.
- Latitude Advisors's Amgen position peaked at $797K in Q1 2022.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Latitude Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.